Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 1, 2006, Pages

  Govoni, Kristen E ^a   Seong, Keun Lee ^a   Chadwick, Robert B ^a,b   Yu, Hongrun ^a   Kasukawa, Yuji ^a   Baylink, David J ^a,b   Mohan, Subburaman ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Insulin like growth factor I; lit lit mouse; Signaling pathways

Indexed keywords

MESSENGER RNA; PHOSPHATE BUFFERED SALINE; RECOMBINANT GROWTH HORMONE; RECOMBINANT OSTEOGENIC PROTEIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN; T BOX TRANSCRIPTION FACTOR; THYMIDINE DERIVATIVE; TRANSCRIPTION FACTOR T BOX 3; UNCLASSIFIED DRUG; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENOME ANALYSIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE TAGGED SITE;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; T-BOX DOMAIN PROTEINS; TRANSFECTION; WNT PROTEINS;

EID: 33745815288     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00592.2005     Document Type: Article

References (46)

1. Ahluwalia A, Clodfelter KH, and Waxman DJ. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic Acid microarray analysis. Mol Endocrinol 18: 747-760, 2004.
2. Attisano L and Labbe E. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 23: 53-61, 2004.
3. Beamer WH and Eicher EM. Stimulation of growth in the little mouse. J Endocrinol 71: 37-45, 1976.
4. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, and Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371, 2001.
5. Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, Mac-Donald ME, van Lohuizen M, and Bernards R. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277: 6567-6572, 2002.
6. Carlson H, Ota S, Campbell CE, and Hurlin PJ. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Hum Mol Genet 10: 2403-2413, 2001.
7. Clevenger CV. Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18: 75-86, 2003.
8. Davenport TG, Jerome-Majewska LA, and Papaioannou VE. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development 130: 2263-2273, 2003.
9. Donahue LR and Beamer WG. Growth hormone deficiency in "little" mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J Endocrinol 136: 91-104, 1993.
10. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, and Conklin BR. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4: R7, 2003.
11. Dorak MT. REAL-TIME PCR [online at tripod.com/genetics/realtime. html" LOCATOR-TYPE="URL"〉http://dorakmt.tripod.com/genetics/ realtime.html], 2005.
12. Eblaghie MC, Song SJ, Kim JY, Akita K, Tickle C, and Jung HS. Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos. J Anat 205: 1-13, 2004.
13. Eicher EM and Beamer WG. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J Hered 67: 87-91, 1976.
14. Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink DJ, Mohan S, and Thoren M. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85: 4104-4112, 2000.
15. Flores-Morales A, Stahlberg N, Tollet-Egnell P, Lundeberg J, Malek RL, Quackenbush J, Lee NH, and Norstedt G. Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology 142: 3163-3176, 2001.
16. Frank SJ. Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm IGF Res 11: 201-212, 2001.
17. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, and Mayo KE. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4: 227-232, 1993.
18. Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, Wewer UM, Christiansen J, and Nielsen FC. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol 24: 4448-4464, 2004.
19. Hedstrom M, Saaf M, Brosjo E, Hurtig C, Sjoberg K, Wesslau A, and Dalen N. Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture: a double-blind placebo-controlled pilot study in 20 patients. Acta Orthop Scand 75: 394-401, 2004.
20. Holmes SJ, Economou G, Whitehouse RW, Adams JE, and Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78: 669-674, 1994.
21. Isaksson OG, Jansson JO, and Gause IA. Growth hormone stimulates longitudinal bone growth directly. Science 216: 1237-1239, 1982.
22. Ito A, Asamoto M, Hokaiwado N, Takahashi S, and Shirai T. Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett 219: 105-112, 2005.
23. Kasukawa Y, Baylink DJ, Guo R, and Mohan S. Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice. Endocrinology 144: 3950-3957, 2003.
24. Li H, Bartold PM, Young WG, Xiao Y, and Waters MJ. Growth hormone induces bone morphogenetic proteins and bone-related proteins in the developing rat periodontium. J Bone Miner Res 16: 1068-1076, 2001.
25. Linkhart TA, Mohan S, and Baylink DJ. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 19: 1S-12S, 1996.
26. Mohan S, Linkhart T, Jennings J, and Baylink D. Chemical and biological characterization of low-molecular-weight human skeletal growth factor. Biochim Biophys Acta 884: 243-250, 1986.
27. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, and Baylink DJ. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144: 929-936, 2003.
28. Monk D, Bentley L, Beechey C, Hitchins M, Peters J, Preece MA, Stanier P, and Moore GE. Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome. J Med Genet 39: 575-581, 2002.
29. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, and Slootweg MC. Growth hormone and bone. Endocr Rev 19: 55-79, 1998.
30. Peirce SK and Chen WY. Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice. Oncogene 23: 1248-1255, 2004.
31. Piwien-Pilipuk G, Huo JS, and Schwartz J. Growth hormone signal transduction. J Pediatr Endocrinol Metab 15: 771-786, 2002.
32. Postel-Vinay MC and Kelly PA. Growth hormone receptor signalling. Baillieres Clin Endocrinol Metab 10: 323-336, 1996.
33. Qin X, Strong DD, Baylink DJ, and Mohan S. Structure-function analysis of the human insulin-like growth factor binding protein-4. J Biol Chem 273: 23509-23516, 1998.
34. Rallis C, Del Buono J, and Logan MP. Tbx3 can alter limb position along the rostrocaudal axis of the developing embryo. Development 132: 1961-1970, 2005.
35. Sanders EJ and Harvey S. Growth hormone as an early embryonic growth and differentiation factor. Anat Embryol (Berl) 209: 1-9, 2004.
36. Smith J. T-box genes: what they do and how they do it. Trends Genet 15: 154-158, 1999.
37. Stevens AM and Yu-Lee LY. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol 8: 345-355, 1994.
38. Sugimoto T, Kaji H, Nakaoka D, Yamauchi M, Yano S, Sugishita T, Baylink DJ, Mohan S, and Chihara K. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis. Eur J Endocrinol 147: 339-348, 2002.
39. Too CK, Knee R, Pinette AL, Li AW, and Murphy PR. Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells. Mol Cell Endocrinol 137: 187-195, 1998.
40. Tumpel S, Sanz-Ezquerro JJ, Isaac A, Eblaghie MC, Dobson J, and Tickle C. Regulation of Tbx3 expression by anteroposterior signalling in vertebrate limb development. Dev Biol 250: 251-262, 2002.
41. Verras M and Sun Z. β-Catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. Mol Endocrinol 19: 391-398, 2005.
42. Wang J, Zhou J, Cheng CM, Kopchick JJ, and Bondy CA. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 180: 247-255, 2004.
43. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, and Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100: 2744-2751, 1997.
44. Westendorf JJ, Kahler RA, and Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 341: 19-39, 2004.
45. Wilson V and Conlon FL. The T-box family. Genome Biol 3: REVIEWS3008, 2002.
46. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S, and Knudsen S. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3: research0048, 2002.